Cite
HARVARD Citation
Quartuccio, L. et al. (2015). Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study. Journal of autoimmunity. pp. 88-93. [Online].